Articles in section Distribution & Marketing

<< Deal Trackers

77 articles

Editorial >>

<< Previous

Pages 1 ..2 3 4 5 6 7 .. 8

Next >>

New Distributor for Cedax® in the US Published: 4 Oct-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 52
Millennium Grants GSK European Marking Rights to Integrilin® Published: 4 Aug-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 50
Abbott Acquires Remaining Rights to Trandolapril from Aventis Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 49
Schering AG Agrees to Commercialise Praecis' Plenaxis™ Published: 4 Jun-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 48
Elan Streamlines CNS Portfolio with Divestment of Two Drugs Published: 4 May-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 47
Mayne to Market Paxene® in the EU Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 46
Shire’s Exit Strategy from Japan Provides Bayer with Exclusive Product Rights Published: 4 Feb-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 44
Yamanouchi to Market Aventis’ Peptic Ulcer Drug Amidst Merger Talks Published: 4 Jan-2004
By: Business Review Editor
Abstract Fulltext:
Volume: 2004 Issue: 43
SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 39
OSI Gains US Marketing Rights for Gelclair™ from Celgene Published: 3 Jul-2003
By: Business Review Editor
Abstract
Volume: 2003 Issue: 38

Login

Username:

Password:

Keep me logged in